Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation
NCT00452205 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2009-08-04
Summary
The purpose of this study is to clarify the relationship bone marrow-derived cells and the formation of the tumors, and the role of these cells in regeneration of epithelial cells in the gastrointestinal tract.
Conditions
- Gastrointestinal Neoplasms
Sponsors & Collaborators
-
Komagome Hospital
lead OTHER
Principal Investigators
-
Naoto Egawa, MD
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-30
- Completion
- 2017-03-31
Countries
- Japan
Study Locations
More Related Trials
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer
NCT02202928 ·Status: UNKNOWN ·Phase: PHASE2
-
Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
NCT02502630 ·Status: COMPLETED ·Phase: NA
-
The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer
NCT01863420 ·Status: UNKNOWN
-
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
NCT01445327 ·Status: TERMINATED
-
Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer
NCT06446050 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients
NCT00502502 ·Status: COMPLETED
-
The Value of MRI in Assessing the Status of Retroperitoneal Resection Margin in Colon Cancer
NCT05859581 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
NCT02022995 ·Status: COMPLETED
-
Metformin for the Prevention of CRA Recurrence
NCT04885426 ·Status: UNKNOWN ·Phase: NA
-
Multicenter Cross Sectional Study of Primary Intestine Lymphoma
NCT01043302 ·Status: COMPLETED
-
The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
NCT04416854 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
NCT06621173 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
NCT06120127 ·Status: RECRUITING ·Phase: PHASE2
-
Prediction of the Efficacy of ctDNA in Immunotherapy for Advanced Gastric Cancer
NCT04053725 ·Status: UNKNOWN
-
A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer
NCT02296658 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)
NCT06205862 ·Status: RECRUITING ·Phase: PHASE2
-
Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer
NCT01848015 ·Status: UNKNOWN
-
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
NCT04917289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Gut Microbiota Reconstruction for NSCLC Immunotherapy
NCT05008861 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
NCT02291744 ·Status: UNKNOWN ·Phase: PHASE2
-
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
NCT05501353 ·Status: RECRUITING
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study
NCT05347524 ·Status: RECRUITING